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Problem
Galectins influence the progress of pregnancy by regulating key pro-
cesses associated with embryo-maternal cross talk, including angiogene-
sis and placentation. Galectin family members exert multiple roles in the
context of hemochorial and epitheliochorial placentation; however, the
galectin prolife in endotheliochorial placenta remains to be investigated.
Method of study
Here, we used immunohistochemistry to analyze galectin (gal)-1, gal-3
and gal-9 expression during early and late endotheliochorial placenta-
tion in two different species (dogs and cats).
Results
We found that during early feline gestation, all three galectin members
were more strongly expressed on trophoblast and maternal vessels com-
pared to the decidua. This was accompanied by an overall decrease of
gal-1, gal-3 and gal-9 expressions in late feline gestation. In canine early
pregnancy, we observed that gal-1 and gal-9 were expressed strongly in
cytotrophoblast (CTB) cells compared to gal-3, and no galectin expression
was observed in syncytiotrophoblast (STB) cells. Progression of canine
gestation was accompanied by increased gal-1 and gal-3 expressions on
STB cells, whereas gal-9 expression remained similar in CTB and STB.
Conclusion
These data suggest that both the maternal and fetal compartments are
characterized by a spatiotemporal regulation of galectin expression dur-
ing endotheliochorial placentation. This strongly suggests the involve-
ment of the galectin family in important developmental processes
during gestation including immunemodulation, trophoblast invasion
and angiogenesis. A conserved functional role for galectins during mam-
malian placental development emerges from these studies.
Introduction
In eutherian mammals, the placenta is a transitory
organ that invades the maternal uterus to provide
nutrition and gas exchange for the developing fetus.
As a consequence of this process, tolerance mecha-
nisms must be employed at the maternal–fetal inter-
face to protect the developing semiallogenic fetus
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from recognition by the maternal immune system.1
According to the extent of trophoblast invasion into
the uterus, placentation can be classified as hemo-
chorial, endotheliochorial or epitheliochorial.
Humans and mice exhibit hemochorial placentation;
the most invasive placental type in which tro-
phoblast cells penetrate the maternal blood vessels
and come into direct contact with maternal blood.2
In contrast, epitheliochorial placentation, character-
istic of large farm animals such as cows, pig and
sheep, is non-invasive, and trophoblast cells simply
attach to the uterine epithelium.3 The third type of
placentation, endotheliochorial, is found in dogs and
cats; here trophoblast cells invade the uterus until
they border the maternal blood vessels.4–6 Regardless
of the type of placentation, this organ ensures nor-
mal growth and development of the embryo and
fetus while supporting pregnancy-related changes in
maternal physiological systems.
Galectins are a family of highly conserved proteins
that mediate numerous biological processes by cross-
linking glycans on cell membranes.7 All members of
this family are composed of a distinct carbohydrate
recognition domain (CRD) with conserved consensus
regions and beta-galactoside specific lectin activity.
While some galectins contain one CRD and are
biologically active as either homodimers (e.g., galec-
tin-1) or oligomers that aggregate through their non-
lectin domain (galectin-3); other galectins contain two
CRDs connected by a short linker peptide (e.g., galec-
tin-9).8 Several members of this family play an active
role in pregnancy maintenance by regulating tro-
phoblast cell growth and differentiation, angiogenesis
and inflammation throughout gestation.9–14 Within
this family, galectin-1 (gal-1), gal-3 and gal-9 are of
particular interest as they are highly expressed at the
maternal–fetal interface.15 Their expression is spa-
tiotemporally regulated during pregnancy, and the
biological function of a particular galectin may vary
according to the site of expression and availability of
particular ligands.8 For instance, gal-1 appears to play
specific roles during implantation, decidualization,
vascularization and later on, during placentation.14,16–18
During early gestational stages, gal-1 exhibits proan-
giogenic functions by promoting decidual vascular
expansion through vascular endothelial growth factor
(VEGF) receptor 2 signaling.12 Putative roles played
by gal-1 during hemochorial placentation include
organization of the extracellular matrix, regulation of
trophoblast differentiation and cell motility17,19,20 and
modulation of class Ib human leukocyte antigen
(HLA) expression;11 the later representing a potent
immunosuppressive mechanism triggered by tro-
phoblast cells.21–23 In addition, gal-1 is also strongly
expressed in immune cells such as decidual natural
killer (NK) cells24 and T regulatory cells (Tregs)25 and
we have demonstrated that this lectin plays a critical
role in immune tolerance by inducing tolerogenic
dendritic cells and the subsequent expansion of IL-10
producing regulatory T cells.9 During epitheliochorial
placentation gal-1 is present in decidual stromal cells
and early gestational trophoblast giant cells.26
Regarding the function of gal-3 and gal-9 during
pregnancy, specific roles for these proteins remain to
be elucidated. Human reports demonstrate that gal-3
expression at the fetal–maternal interface partially
overlaps that of gal-1.17,27 In mice, uterine gal-3
expression is selectively upregulated within the
decidua during early stages of pregnancy, whereas at
later stages it is predominantly expressed in the pla-
centa.28 Furthermore, decreased implantation rates
were observed upon tissue-specific gal-3 knockdown
in the murine uterus,29 suggesting a role for this lec-
tin during the embryo-maternal cross talk driving
implantation. Little information is available on
epitheliochorial placentation where gal-3 is confined
to uterine epithelial cells.26 As for gal-9, this lectin is
substantially upregulated in human decidua com-
pared to proliferative endometrium.30 We recently
showed the expression of at least six gal-9 isoforms
in decidual tissue, and that the Lgals9 D5 variant can
selectively suppress IFN-c production by uterine NK
cells.13 Finally, expression of gal-9 has also been
reported in the epitheliochorial placenta, though at
lower levels than in the decidual compartment.26
Although the role that galectins play in placentation
is presently a topic of much interest, the information
concentrates mainly on the hemochorial placental
type. Information on the involvement of galectins in
endotheliochorial and epitheliochorial placental types
is minimal, and limited mainly to farm relevant ani-
mals such as cows,26 sheep31,32 and goats.33 To our
knowledge there are presently no studies investigating
galectin expression in endotheliochorial placental
mammals such as dogs and cats. As a first step in illu-
minating this subject, the objective of this research
was to examine gal-1, gal-3 and gal-9 expression pat-
terns at the feto-maternal interface in cats and dogs,
and to identify changes in expression between early
and late gestation. This new knowledge will provide a
strong foundation for galectin research and pregnancy
in veterinary relevant species.
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Materials and methods
Tissue Collection
The cat (Felis catus) and dog (Canis lupus familiaris)
specimens for this study were obtained with owners’
approval, during hysterectomy or Cesarean section
at the University of La Plata. All procedures were
approved by the Universidad Nacional de La Plata
ethical committee. Gestational ages were estimated
by embryo or fetal length. Average gestation length
for dogs and cats is 63–65 days. Accordingly, samples
were collected at estimated period of gestation: early
(<30 days) or late (>45 days). For each estimated
period of gestation, more than one visible embryonic
vesicle was used in the study: early (n = 7 dogs and
4 cats), late (n = 5 dogs and 4 cats). We collected
samples of different fetal sacs from each mother. The
samples included central areas of placental girdle
and excluded marginal hematoma. Maternal and
embryo or fetal placental structures were collected
and fixed in buffered formalin for 24 h following
our standard protocol.12
Immunohistochemistry
After deparaffinization and rehydration, serial dog
and cat paraffin-embedded tissue sections (4 lm)
were washed in TBS, followed by blocking of
endogenous peroxidase (PO) through incubation
with 3% H2O2 in methanol for 30 min at room tem-
perature. After incubation with 2% normal serum
for 20 min, primary antibodies rabbit against gal-1
(1:500, sc-28248), gal-3 (1:200, sc-20157) and goat
against gal-9 (1:100, sc-19292, all purchased from
Santa Cruz Biotechnology) were incubated overnight
at 4°C. The slides were then washed and incubated
for 1 hr at room temperature with goat anti-rabbit
PO-conjugated secondary Ab (1:200, cat. #111-035-
003, ImmunoResearch) for gal-1 and gal-3 determi-
nation or donkey anti-goat PO-conjugated secondary
Ab (1:200, cat. #705-035-147 Jackson ImmunoRe-
search) for gal-9. The signal was detected using a liq-
uid DAB + Substrate Chromogen System (cat.
#K3467, DAKO) at room temperature. After wash-
ing, nuclei were counterstained with 0.1% Mayer’s
hematoxylin followed by a standard dehydration
procedure and mounting in Vitro-Clud medium (R.
Langenbrinck, Germany). Negative controls were
run in parallel for each galectin primary antibody.
Briefly, we pre-absorbed the rabbit anti-gal-1, gal-3
or gal-9 primary antibody with the respective block-
ing peptide (overnight at 4°C), and then proceeded
with the above described protocol. Negative controls
showed no specific immuno-reactivity. For overview,
image tissue sections were stained with hematoxylin
and eosin (H&E).
Analysis
Analysis of galectin-stained slides was performed
using a Keyence BZ9000 microscope and by three
independent observers. Images were taken at differ-
ent magnifications for each staining. In both species,
galectin expression of labyrinthine structures was
described, taking into account: maternal vessels
(mv), syncytiotrophoblast (STB) and cytotrophoblast
(CTB), fetal mesenchyma (fm) and fetal vessels (fv).
Galectin expression in the decidual cells of the cat
placenta was also assessed. Each observer quantified
staining of the respective galectins in the mentioned
placental structures with the following score: strong
(+++), moderate (++), weak (+) staining and nega-
tive (). Furthermore, positive cells were quantified
by counting within the different areas in each tissue
sample including mv, STB, CTB, fm, fv and decidua
(Dec). For each sample, at least four different regions
(i.e., fields) were recorded. Percentage of positive
cells was expressed as a mean count for each of the
analyzed group.
Results
Differential Expression of gal-1, gal-3 and gal-9
Between Early and Late Healthy Feline Gestation
Early feline gestation samples showed expression of
gal-1, gal-3 and gal-9 within the trophoblast cyto-
plasm, maternal vessels and decidual cytoplasm
(Fig. 1a–d; Table I, Figure S1a). In all galectin stain-
ings, the cyto- and syncytiotrophoblasts and mater-
nal vessels stained more strongly than decidual
tissue (Fig. 1b–d). Interestingly, comparing between
the different galectin stainings, gal-3 and gal-9 were
more strongly expressed than gal-1 in early gesta-
tion. The fetal mesenchyma only expressed low
levels of gal-1 (Fig. 1b). The fetal vessels were nega-
tive for all three galectins tested. Also noteworthy,
strong cytoplasmic expression of gal-9 was observed
in approximately 25% of decidual stromal cells
(Figs 1d and S1a). No nuclear staining was evident
in any of the cell types observed.
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Analysis of mature feline placenta revealed that
gal-1 was moderately expressed at similar levels in
maternal vessels, the trophoblast and the cytoplasm
of decidual cells (Fig. 2b; Table I, Figure S1b). Inter-
estingly, the nuclei of decidual cells were also
stained. However, gal-1 expression was almost
absent from the fetal vessels during late gestation,
while the fetal mesenchyma started to express gal-1
at low levels (Fig. 2b). Gal-3 expression in mature
placenta was also increased overall when compared
with early pregnancy samples; however, the stain-
ing pattern remained the same with the trophoblast
cell cytoplasm and maternal blood vessels staining
more strongly than decidual cell cytoplasm. The
fetal mesenchyma was weakly stained for gal-3
(Figs 2c and S1b). As for gal-9, a differential pattern
of expression was observed between early and late
stages of feline gestations. Maternal vessel and tro-
phoblast expression of gal-9 decreased in the mature
placenta but decidual cells maintained strong
expression. Additionally, the decidual cells presented
a nuclear staining. The syncytio- and cytotro-
phoblasts displayed a vesicular rather than uniform
staining in the cytoplasm. The fetal mesenchyma
exhibited moderate gal-9 expression in all areas of
the mature placenta (Figs 2d and S1b), whereas the
fetal vessels were negative for all galectins during
late gestation.
Spatiotemporal Expression of gal-1, gal-3 and gal-
9 During Normal Canine Gestation
Staining of early canine gestation placental samples
revealed that the CTB expresses all three galectins:
gal-1 and gal-9 were strongly stained while gal-3
was only weakly expressed (Fig. 3a–d, Table II, Fig-
ure S1c). No galectin expression was observed in the
STB in early gestation. Maternal blood vessels also
expressed gal-3 and gal-9 and no staining of fetal
vessels was observed (Fig. 3c,d). When analyzing
late canine gestation samples, gal-1 expression was
evident in maternal vessels and surrounding STB
cells (Fig. 4a–d, Table II, Figure S1d). This lectin was
also expressed in CTB, albeit more weakly than in
(a)
(b) (c) (d)
Fig. 1 Galectins expression during early
feline gestation. (a) Left panel: Representative
overview image of hematoxylin and eosin
(H&E) staining in the labyrinth of
endotheliochorial early (<30 days) feline
placenta. Scale bar = 100 lm; magnification
1009. Right panel: Scale bar = 25 lm;
magnification 4009. (b–d) Representative
photomicrographs of gal-1 (b), gal-3 (c) and
gal-9 (d) staining at the maternal–fetal
interface of early (<30 days) healthy feline
gestations. Bar represents 25 lm;
magnification 4009. Dec, decidua; mv,
maternal vessel; CTB, cytotrophoblast; STB,
syncytiotrophoblast; fv, fetal vessels; fm, fetal
mesenchyme.
Table I Quantification of Galectin Distribution in Early and Late
Feline Placenta Samples
Placental structure Gestation gal-1 gal-3 gal-9
Maternal vessels Early ++ ++ ++(+)
Late ++ +++ +(+)
Syncytiotrophoblast Early ++ ++ ++
Late ++ +++ ++
Cytotrophoblast Early + ++ +++
Late ++ +++ ++
Fetal mesenchyma Early   
Late + + ++
Fetal vessels Early +  
Late   
Decidua Early + + ++(+)
Late ++ + ++(+)
Quantification of staining: strong +++, moderate ++, weak +,
negative . Brackets are indicative of heterogeneity of labeling
intensities [i.e., ++(+) weak to moderate staining].
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early gestation. Regarding gal-3 expression in late
canine gestation, we found immunoreactivity only
in STB cytoplasm, whereas no CTB staining was
observed. In addition, maternal vessels and fetal
mesenchyma also weakly expressed gal-3 (Fig. 4c).
Finally, gal-9 expression was detected in maternal
vessels and all trophoblast cell populations, with
most strong labeling in the CTB and STB cytoplasm.
However, the CTB gal-9 expression was heteroge-
neous (Fig. 4d).
(a)
(b) (c) (d)
Fig. 2 Galectins expression pattern in late
feline endotheliochorial placentation. (a) Left
panel: Representative overview image of
hematoxylin & eosin (H&E) staining in the
labyrinth of endotheliochorial late (>35 days)
feline placenta. Scale bar = 100 lm;
magnification 1009. Right panel: Scale
bar = 25 lm; magnification 4009. (b–d)
Representative examples of gal-1 (b), gal-3 (c)
and gal-9 (d) staining at the maternal–fetal
interface of late (>45 days) healthy feline
gestations. Insert on the bottom left of each
panel show negative controls for gal-1 (b),
gal-3 (c) and gal-9 (d) staining. Bar represents
25 lm; magnification 4009. Dec, decidua;
mv, maternal vessel; CTB, cytotrophoblast;
STB, syncytiotrophoblast; fv, fetal vessels; fm,
fetal mesenchyme.
(a) (b)
(c)
(d)
Fig. 3 Characterization of galectin expression patterns during early canine endotheliochorial placentation. (a) Top panel: Representative H&E
staining shows the maternal zone (Mz), Junctional zone (Jz) and labyrinth (Lab) of the endotheliochorial early canine placenta (<30 days). Scale
bar = 250 lm; magnification 509. Bottom panels: Details of the maternal zone (Mz), Junctional zone (Jz) and labyrinth (Lab) of the
endotheliochorial canine placenta during early are shown. Bars represent 25 lm; magnification 4009. (b–d) Representative examples of gal-1 (b),
gal-3 (c) and gal-9 (d) staining showing the maternal zone (left), junctional zone (middle) and labyrinth (right) panels of the maternal–fetal interface
during early stage (<30 days) healthy canine gestation. Scale bar represent 25 lm; magnification 4009. CTB, cytotrophoblast; STB,
syncytiotrophoblast; fv, fetal vessels; fm, fetal mesenchyme; mv, maternal vessel.
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Discussion
Studies in reproductive tissues from different species
have provided important insights into the role
played by galectins in pregnancy. As a delicate inter-
play between maternal and fetal galectin expression
is critical for healthy gestation, identification of
galectin profiles in placental types with different
invasive capacities can help to understand the roles
of these important molecules. In this study, we pro-
vide the first evidence that endotheliochorial placen-
tas (both canine and feline) have a temporal and cell
specific expression of three galectin members from
early to late gestation.
Galectins display a unique combination of biologi-
cal functions, with immunemodulation at the feto-
maternal interface being one of the best-described
mechanisms of this lectin family.34 Here, we show
that gal-1, gal-3 and gal-9 are expressed during early
gestation in endotheliochorial placentation, implying
that these galectins could also contribute to the
protection of canine and feline embryos from attack
by the maternal immune system. In this context,
canine embryos do not express major histocompati-
bility complex (MHC) I and II but express FasL,
preventing their recognition as foreign antigens and
eliminating Fas-bearing cytotoxic maternal T cells,
respectively.35 Interestingly, Fas/Apo-1 has been
identified as a target for gal-1 recognition in Jurkat
cells, sensitizing them to caspase-8 mediated apopto-
sis.36 Thus, gal-1 expression in early gestation
endotheliochorial placentas could constitute a com-
plementary mechanism contributing to feto-maternal
tolerance, which is consistent with its described role
facilitating the apoptosis of activated maternal T cells
and inducing Treg cells in hemochorial placenta-
tion.9,10 Similarly to gal-1, gal-9 also functions as an
anti-inflammatory signal that influences T-cell sur-
vival by promoting Treg and suppressing Th17 cell
activity,37 and therefore, its expression during early
endotheliochorial placentation could be involved in
promoting feto-maternal tolerance. Additionally, our
study showed that gal-3 expression was abundant
during early endotheliochorial gestation, whereas its
expression decreased at later stages. This distribution
could imply a role of this lectin in the embryo-
maternal cross talk driving implantation, as a similar
pattern of gal-3 expression has been found in hemo-
chorial placentation during early gestation.18,27,28
Besides their roles in immunemodulation, galectins
also modulate angiogenic responses in vitro and
in vivo by influencing endothelial cell activation, pro-
liferation, migration and tube formation.38 During
early endotheliochorial placentation, localization of
gal-1, gal-3 and gal-9 to the endothelia of maternal
blood vessels within the labyrinth could represent a
marker of endothelial cell activation. This is in agree-
ment with studies that show increased galectin
expression in the maternal associated vasculature
during hemochorial placentation39 and tumorigene-
sis.40–42 As VEGF signaling is increased during the
early stages of endotheliochorial placentation,35 it is
tempting to speculate that the expression of these
three galectins in the maternal vessel endothelia
could contribute to the angiogenesis process. Sup-
porting this notion, gal-1 interacts with neuropilin to
promote signaling via the VEGF receptor 2,43
enhances H-Ras signaling in endothelial cells44 and is
associated with fetal growth delay in Lgals-1 deficient
mice due to hampered placental vascularization.12
Similarly to gal-1, gal-3 also exhibits pro-angio-
genic functions. Gal-3 binding to amb3 integrin mod-
ulates VEGF and basic fibroblast growth factor
(bFGF)-mediated angiogenesis,45 and can also acti-
vate VEGFR2 by regulating receptor internaliza-
tion.46 Notably, studies profiling the expression of
the VEGF system in canine and mink endotheliocho-
rial placentas have demonstrated that the VEGFR2 is
the predominant receptor expressed on microvascu-
lar endothelial cells during early pregnancy.47,48 This
expression largely correlates with the pattern
described for several matrix metalloproteases (MMP)
in canine and feline pregnancies,49,50 particularly
with MMP-2 and MMP-9. MMP-2 and MMP-9 target
Table II Quantification of Immunohistochemical Detection of
Galectin Expression in Early and Late Canine Gestation
Placental structure Gestation gal-1 gal-3 gal-9
Maternal vessels Early  ++ ++
Late ++ + +
Syncytiotrophoblast Early   
Late ++ ++ +++
Cytotrophoblast Early +++ + +++
Late +  ++(+)
Fetal mesenchyma Early   
Late   
Fetal vessels Early   
Late  + 
Quantification of staining: strong +++, moderate ++, weak +,
negative . Brackets are indicative of heterogeneity of labeling
intensities [i.e., ++(+) weak to moderate staining].
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the non-galectin domain of gal-3, enhancing the
chemotactic properties of this lectin toward endothe-
lial cells and promoting migration and onset of
angiogenesis.51 While pro-angiogenic functions of
gal-9 are still elusive, Heusschen et al.42 demon-
strated that the endogenous Lgals9D5 is able to
influence human endothelial cell proliferation
in vitro, suggesting that this splice variant of gal-9
can modulate angiogenesis in vivo. Together, these
findings suggest that galectin expression on maternal
blood vessel endothelia in the labyrinth is likely
associated with angiogenesis in the canine and feline
placenta. These results encourage further studies on
galectin interaction with the VEGF system during
early endotheliochorial placentation.
Within endotheliochorial placentation, comparison
of galectin expression from early to late gestation in
feline and canine placentas revealed some striking
differences. In the feline placenta, gal-1, gal-3 and
gal-9 were expressed in both CTB and STB, whereas
at later stages these galectins were more weakly
expressed in the trophoblast. This suggests that pro-
gression of endotheliochorial placentation leads to a
decrease in galectin expression. Contrasting this,
analysis of canine early gestation trophoblast cells
revealed that only the CTB expressed gal-1, gal-3
and gal-9. In late canine gestation, galectin expres-
sion decreased in the CTB and appeared in the STB,
suggesting a gain of galectin expression in canines as
CTB differentiates into STB. These results appear to
contradict findings in human hemochorial place-
ntation, where gal-1 expression is lost during the
differentiation of CTB to STB.11 These contradict-
ory results may be due to the different degree of
(a) (b)
(c)
(d)
Fig. 4 Distribution of galectins at the maternal–fetal interface during late (>35 days) normal canine pregnancies. Top panel: Representative H&E
staining shows the maternal zone (Mz), Junctional zone (Jz) and labyrinth (Lab) of the endotheliochorial late canine placenta during late (>45 days).
Scale bar = 250 lm; magnification 259. Bottom panels: Details of the Junctional zone (Jz) and labyrinth (Lab) of the endotheliochorial canine
placenta during late are shown. Bars represent 25 lm; magnification 4009. (b–d) Representative images of gal-1 (b), gal-3 (c) and gal-9 (d)
immunohistochemical staining in the junctional zone (left) and labyrinth (right) of the endotheliochorial canine placenta are shown. Inserts show
negative controls. CTB, cytotrophoblast; STB, syncytiotrophoblast; eCTB, extra villous CTB; fv, fetal vessels; fm, fetal mesenchyme; mv, maternal
vessel.
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trophoblast invasiveness in hemochorial and
endotheliochorial placentation and may also account
for the finding that decidual galectin expression (-1,
-3 and 9) appears to be lower in canine and feline
specimens than in species with deeper invasion such
as mice and humans.
The spatiotemporal expression of gal-1, gal-3 and
gal-9 in the endotheliochorial placenta provides
clues into the roles of these molecules in pregnancy.
Research into species with alternative placental
strategies can help to unravel the fine details of
galectin function, specifically with regard to immune
tolerance and angiogenesis at the maternal–fetal
interface.
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